News and events
Read about the latest developments at NorthX Biologics and find out more about relevant happenings in the industry.
May 31- June 3rd, 2023
International Society for Cell and Gene Therapy (ISCT) Annual Meeting takes an integrative approach across all stakeholders to address key topics spanning translational research and preclinical development through to clinical trials, regulatory approvals, commercialization and ultimately patient access.
May 16 th - 20th.
The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for professionals in gene and cell therapy.
Feb 28th - March 2nd.
Nu kan man läsa den spännande artikeln om innovationsfabriken på Dagens Industri.
We are proud to inform you that NorthX Biologics improved its score from bronze to silver in the International Sustainability Survey (EcoVadis) for year 2022!
CGTI leaders Summit 2023 February 15th 2023
Advanced Therapies Week is an event like no other!
Conference "Advanced Biologics in Matfors and Beyond" at NorthX Bio went to a big success!
Xintela och NorthX Biologics tillkännager att de har tecknat ett samarbetsramavtal för att gemensamt accelerera utveckling av avancerade terapier (ATMP) genom att tillvarata bolagens kompletterande kompetens och resurser inom ATMP-utveckling och GMP-tillverkning. Projekt som ska initieras inom ramen för samarbetet inkluderar bland annat produkt- och processutveckling, kvalitetsstyrning och utökad expansionskapacitet för tillverkning av ATMPer
The coming ATMP workshop will be host by NorthX Bio Matfors on the 14-15th December. Click on "Read more" to get the detailed program!
The world’s leading expo in the life sciences BIO-Europe will host its first in-person edition since 2019 in Leipziger Messe on 24 – 26 October.
Chetan is attending the Meeting on the Mesa event. Come and meet us !
NorthX Biologics (“NorthX”) styrelse har utsett Helena Strigård till ny vd. Hon kommer närmast från rollen som vd för branschorganisationen SwedenBIO. Helena kommer att leda NorthX fortsatta expansion av avancerad utveckling och produktion av biologiska läkemedel. Ted Fjällman, vd i NorthX och partner i huvudägaren Flerie Invest, fortsätter som ledamot i styrelsen.
MATFORS, Sweden, September 20, 2022 - The Board of NorthX Biologics ("NorthX") has appointed Helena Strigård as the new CEO. She joins NorthX from her role as Director General for the Swedish life science industry organization, SwedenBIO. Helena will lead NorthX's continued expansion in the development and production of advanced biologics. Ted Fjällman, current CEO of NorthX and Partner of the Company’s main investor, Flerie Invest, will continue to support the company as a member of the Board.
Please register to the seminar "Drug Development of Today and the Future" on the 19th of October!
New Horizons in Biologics & Bioprocessing, December 15th 2022
NorthX Biologics appoints industry veterans to its board of directors
Idag kan vi meddela att vi expanderar inom produktion av cellterapi bl.a. via partnerskap med Alder Therapeutics samt att vi expanderar med en andra tillverkningsanläggning på Karolinska.
2022-06-21
June 13-16, 2022・San Diego, CA
We are excited to be exhibiting at BIO USA this year. Come stop by our booth (#1054) or contact us to schedule a meeting.
"We welcome Dave Smith from Akron Bio and Ola Tuvesson from NorthX Biologics to present and discuss the critical functions of CMOs and their role in managing the challenges of adapting from traditional biologics to ATMPs."
Currently, mRNA medicines, such as vaccines, require freezers that can maintain −80 °C for large-scale handling and distribution. A new project has now started, with an aim to develop production processes for manufacturing mRNA medicines that remain stable even at 4 °C or higher. - The goal is to develop a dry vaccine, which would open up completely new opportunities for handling and distribution, says Randi Nordström, a researcher in formulation development at RISE.
Nordic Life Science Days (nlsd) is the largest Nordic partnering conference dedicated to the life science industry. The event attracts leading decision makers from biotech, pharma and med tech, as well as finance, research, policy and regulatory authorities.
The world tour is back! With more ’world leading’ activities within ATMP, highlighting and discussing the partnerships, infrastructures and competences critical to successes in our field.